• Sign In
  • Sign Up
    Loading ...
View All Updates Mark All Read
THE FREE WORLD PRESS ~ Paul Coulbeck, Chatham-Kent--Leamington Marijuana Party
  • Home
  • Members
  • Albums
  • Classifieds
  • Blogs
  • Polls
  • Forum
  • Chat
  • Groups
  • Events
  • Videos
  • Music

Member Info

  • Profile Type: Regular Member
  • Profile Views: 2,012 views
  • Friends: 0 friends
  • Last Update: December 27, 2021
  • Joined: July 12, 2021
  • Updates
  • Info
  • Albums(1)
  • Blogs(45)

Updates

The post was not added to the feed. Please check your privacy settings.
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    Progressive supranuclear palsy (PSP) therapies market.
    Progressive supranuclear palsy (PSP) therapies market.
    A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers
     
    Roots Ana...
    • December 27, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    Patient Recruitment and Retention Services Marker, 2019-2030 by
    Patient Recruitment and Retention Services Marker, 2019-2030 by
    A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers
     
    Roots Ana...
    • December 27, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The light activated therapies market is anticipated to grow at
    The light activated therapies market is anticipated to grow at
    Light activated therapies are considered to be a transformative approach owing to their capability to eradicate diseased cells from the body with minimal side effects; presenting lucrative opportunities for players engaged in the development of such produ...
    • December 27, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    COMPANY COMPETITIVENESS ANALYSIS - ATTAINING A COMPETITIVE EDGE
    COMPANY COMPETITIVENESS ANALYSIS - ATTAINING A COMPETITIVE EDGE
    Industry stakeholders are steadily expanding their existing capabilities in order to enhance their respective product portfolios and maintain a competitive edge in this steadily evolving market. The companies considered in this analysis have been divided ...
    • December 20, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The light activated therapies market is anticipated to grow at
    The light activated therapies market is anticipated to grow at
    Light activated therapies are considered to be a transformative approach owing to their capability to eradicate diseased cells from the body with minimal side effects; presenting lucrative opportunities for players engaged in the development of such produ...
    • December 20, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The vascular disrupting agents market is projected to be worth
    The vascular disrupting agents market is projected to be worth
     
    Vascular disrupting agents (VDAs) are the novel oncology drugs being developed to more specifically combat complex, life threatening cancer indications
     
    Roots Analysis is pleased to announce the publication of its recent study, titled, &ld...
    • December 13, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The soft tissue sarcoma market is projected to be worth over US
    The soft tissue sarcoma market is projected to be worth over US
    Recent advances in molecular biology have enabled researchers to develop a better understanding of the rare soft tissue sarcomas; as a result, a number of viable biological targets have been identified and are being investigated for therapeutic relevance
    ...
    • December 13, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The TIL-based therapies market is projected to grow at an annua
    The TIL-based therapies market is projected to grow at an annua
    Driven by the potential to confer sustained therapeutic effects and thereby facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status
    &nbs...
    • December 13, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    Alzheimer's Disease Market by Roots Analysis
    Alzheimer's Disease Market by Roots Analysis
    The recent approval of Aduhelm™, an amyloid beta-directed antibody has led to players seeking approval for similar therapies; various interventions are being evaluated for the treatment / management of the inherently complex neurodegenerative diseas...
    • December 6, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    Presently, close to 140 companies claim to be actively engaged
    Presently, close to 140 companies claim to be actively engaged
    A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of specialty service providers. Presently, clos...
    • December 6, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    Human Microbiome-based Products Market is projected to be worth
    Human Microbiome-based Products Market is projected to be worth
    Over the years, extensive R&D efforts have enabled microbiome-based therapy / diagnostic developers to make significant strides, in terms of progressing proprietary product candidates into the clinic
     
    Roots Analysis has announced the addition of &...
    • December 6, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    Continuous Manufacturing Market by Roots Analysis
    Continuous Manufacturing Market by Roots Analysis
    To order this 310+ page report, which features 110+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html
     
    Key Inclusions

    A detailed assessment of the overall landscap...
    • November 29, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    TIL-based Therapies Market by Roots Analysis
    TIL-based Therapies Market by Roots Analysis
    Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report to its list of offerings.
     
    The report features an extensive study of the current market landscape, offering an informed opinion on the likely a...
    • November 29, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    Polycystic Ovary Syndrome Market by Roots Analysis
    Polycystic Ovary Syndrome Market by Roots Analysis
    Polycystic ovary syndrome affects 1 in 10 women of childbearing age. The exact cause of the condition is unknown; however, obesity, high levels of inflammation and insulin resistance are the common risk factors
     
    London
     
    Roots Analysis has ...
    • November 29, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The bioprocess controllers and automation systems market is pro
    The bioprocess controllers and automation systems market is pro
    Owing to their advanced features and cost saving potential, bioprocess controllers and automation systems have been adopted widely by stakeholders in order to optimize and fasten the manufacturing process of biologics
     
    Roots Analysis is pleased to...
    • November 15, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    Continuous Manufacturing Market by Roots Analysis
    Continuous Manufacturing Market by Roots Analysis
    To order this 310+ page report, which features 110+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html
     
    Key Inclusions

    A detailed assessment of the overall landscap...
    • November 15, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    Elastomeric Closure Components Market by Roots Analysis
    Elastomeric Closure Components Market by Roots Analysis
    To order this detailed 400+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/elastomeric-closures-market-focus-on-parenteral-containers-2019-2030/255.html
     
    Key Inclusions

    A detailed assessment of the current ...
    • November 15, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    Next Generation Immune Checkpoint Inhibitors and Stimulators Ma
    Next Generation Immune Checkpoint Inhibitors and Stimulators Ma
    Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential, both as monotherapies and in combination with other interventions, across multiple disease interventions
     
    Roots A...
    • November 11, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    Neoantigen Targeted Therapies Market, 2019-2030
    Neoantigen Targeted Therapies Market, 2019-2030
    Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential, both as monotherapies and in combination with other interventions, across multiple disease interventions
     
    Roots A...
    • November 11, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    Peptides and Macrocycle Drug Discovery: Services and Platforms
    Peptides and Macrocycle Drug Discovery: Services and Platforms
    Given the recent developments in healthcare, supporting safety and efficacy of peptide and affiliated macrocycle drugs, the industry is presently witnessing an increase in discovery and development initiatives related to such therapeutic modalities.
    &nbs...
    • November 11, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The TIL-based therapies market is projected to be worth over US
    The TIL-based therapies market is projected to be worth over US
    Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status
    &nb...
    • November 1, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The vascular disrupting agents market is projected to be worth
    The vascular disrupting agents market is projected to be worth
    Vascular disrupting agents (VDAs) are the novel oncology drugs being developed to more specifically combat complex, life threatening cancer indications
     
    London
     
    Roots Analysis has announced the addition of “Vascular Disrupting Agents...
    • November 1, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The viral and non-viral vector manufacturing market is projecte
    The viral and non-viral vector manufacturing market is projecte
     
    The rapidly growing pipeline of genetically modified therapies reflects the surge in demand for high quality vectors, presenting lucrative opportunities for companies with the capabilities to manufacture viral and non-viral gene delivery solutions...
    • November 1, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The synthetic lethality-based drugs and targets market is estim
    The synthetic lethality-based drugs and targets market is estim
    Advances in molecular screening technology have enabled the identification of novel synthetic lethal gene combinations, enabling the development of lead candidates that leverage the aforementioned phenomenon to offer therapeutic benefit.
     
    Roots An...
    • October 25, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The targeted protein degradation market is projected to grow at
    The targeted protein degradation market is projected to grow at
    Roots Analysis has done a detailed study on Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PROTACs, Pr...
    • October 25, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The blood-brain barrier (BBB) penetrating drugs market is estim
    The blood-brain barrier (BBB) penetrating drugs market is estim
    Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across brain ca...
    • October 18, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The prefilled syringe fill / finish services market is estimate
    The prefilled syringe fill / finish services market is estimate
    The numerous benefits offered by prefilled syringes, coupled to the growing self-medication trend, have led to the approval of a number of drugs in combination with such devices, resulting in an increase in need to outsource fill / finish operations
    &nbs...
    • October 18, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The fragment-based drug discovery market is estimated to be wor
    The fragment-based drug discovery market is estimated to be wor
    Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery
     
    ...
    • October 18, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The oligonucleotide synthesis, modification and purification se
    The oligonucleotide synthesis, modification and purification se
    The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to complexities associated with the synthesis and processing of these molecules, such operations are usually outsourced to capable CMOs
     
    Ro...
    • October 11, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The ophthalmic drugs contract manufacturing market is estimated
    The ophthalmic drugs contract manufacturing market is estimated
    Outsourcing has become a popular trend among ophthalmic drug developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages
     
    Roots Analysis is pleased to ...
    • October 11, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The patient recruitment and retention services market is estima
    The patient recruitment and retention services market is estima
    A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers
    Roots Analysis is ...
    • October 11, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The antibody contract manufacturing market is projected to reac
    The antibody contract manufacturing market is projected to reac
    With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone
     
    Roots Analysis...
    • October 4, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The Companion Diagnostics Development Services Market is estima
    The Companion Diagnostics Development Services Market is estima
    In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise
     
    Root...
    • October 4, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The biopharmaceutical contract biomanufacturing market growing
    The biopharmaceutical contract biomanufacturing market growing
    Owing to the complexities associated with the production of biologics, biopharmaceutical developers are likely to continue relying on contract service providers for various aspects of their respective product development programs
    London
    Roots Analysis h...
    • September 27, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The CAR-T therapies market is characterized by a healthy pipeli
    The CAR-T therapies market is characterized by a healthy pipeli
    Given the success of approved CAR-T cell therapies, such as KYMRIAH®, YESCARTA®, TECARTUS® and BREYANZI®, this upcoming class of biologics are anticipated to carve out a significant share of the multi-billion dollar cancer immunotherapy ma...
    • September 27, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The antibody contract manufacturing market is projected to reac
    The antibody contract manufacturing market is projected to reac
    With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone
     
    Roots Analysis...
    • September 27, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    Oligonucleotide Synthesis, Modification and Purification Servic
    Oligonucleotide Synthesis, Modification and Purification Servic
    To order this 300+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html
     
    Key Inclusions

    A detailed review of the current status of the market with respect to oligonucleotide man...
    • September 20, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    Over 300 CROs presently claim to possess the necessary capabili
    Over 300 CROs presently claim to possess the necessary capabili
    Given the complex R&D protocols and the increasing demand for clinical evidence of therapeutic benefit, there seems to be a lucrative opportunity for contract research providers engaged in the medical devices’ domain. In fact, since 2000, 150 new CR...
    • September 20, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    In vitro ADME testing services market is likely to be worth USD
    In vitro ADME testing services market is likely to be worth USD
    With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME) properties and inherent toxicity, industry players are actively looking for m...
    • September 20, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The antibody contract manufacturing market is  growing at an an
    The antibody contract manufacturing market is growing at an an
    With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone
     
    Roots Analysis...
    • September 13, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The study features in-depth analyses, highlighting the capabili
    The study features in-depth analyses, highlighting the capabili
    To order this detailed 780+ page report, please visit this link
     
    Key Inclusions

    A detailed review of the overall landscape of the biopharmaceutical contract manufacturing market, featuring an elaborate list of active CMOs, along with informatio...
    • September 13, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    The bispecific antibody therapeutics market is estimated to be
    The bispecific antibody therapeutics market is estimated to be
    Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science commun...
    • September 13, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    Medical Device Batteries: Focus on Implants and Wearable Medica
    Medical Device Batteries: Focus on Implants and Wearable Medica
    An exponential increase in development efforts related to wearable medical devices and implants, has fueled a corresponding rise in demand for safe, compact, light-weight and high energy density batteries with longer life span
     
    Roots Analysis has ...
    • September 6, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    Novel Vaccine Delivery Devices Market, 2019-2030 by Roots Analy
    Novel Vaccine Delivery Devices Market, 2019-2030 by Roots Analy
    Owning to a variety of relevant reasons, which include trypanophobia and dependence on the cold chain, there is an evident demand for innovative and user-friendly vaccine delivery systems that are also safe and efficient
     
    Roots Analysis is pleased...
    • September 6, 2021
  • Kevin Doe
    Kevin Doe wrote a new blog entry:
    Next Generation Immune Checkpoint Inhibitors and Stimulators Ma
    Next Generation Immune Checkpoint Inhibitors and Stimulators Ma
    Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential, both as monotherapies and in combination with other interventions, across multiple disease interventions
     
    Roots A...
    • August 30, 2021
  • Kevin Doe
    Kevin Doe Nearly 300
    non-invasive diagnostic tests, Claims Roots...  more
    Nearly 300
    non-invasive diagnostic tests, Claims Roots Analysis




    Given the invasive
    and cost-intensive nature of tissue biopsies, there is a significant unmet need
    for safer and more patient-friendly cancer diagnostics that are capable of
    offering highly accurate, and actionable insights related to the disease.





    To order this 350+
    page report, which features 150+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html





    The financial opportunity within the liquid biopsy and
    other non-invasive cancer diagnostics market has been analyzed across the
    following segments:


    § Type
    of Tumor Marker


    ctDNA
    cfDNA
    CTCs
    Exosomes
    Others






    § Application


    Diagnosis / Early Diagnosis
    Patient Monitoring
    Recurrence Monitoring






    § Target
    Cancer Indication


    Breast Cancer
    Lung Cancer
    Colorectal Cancer
    Prostate Cancer
    Bladder Cancer
    Melanoma
    Gastric Cancer
    Pancreatic Cancer
    Ovarian Cancer
    ...    less
    • August 23, 2021
  • Kevin Doe
    Kevin Doe Interestingly, the
    majority (>55%) of such service providers firms are based in Europe,
    claims Roots Analysis

    ...  more
    Interestingly, the
    majority (>55%) of such service providers firms are based in Europe,
    claims Roots Analysis




    Repurposing
    of marketed / shelved / pipeline candidates for the treatment of diseases
    (different from original target indications) has emerged as a viable business
    strategy. The rising popularity of this approach can further be attributed to
    various benefits, such as reduced development timelines, decreased investments
    and relatively higher success rates (considering that the safety profiles of
    such candidates have already been established).





    To order this 250+ page report, which features 100+ figures
    and 140+ tables, please visit this - https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html





    The
    USD 1.2 billion (by 2030) financial opportunity within the drug repurposing
    service providers market has been analyzed across the following segments:


    § Type
    of Repurposing Approaches


    § Disease-centric
    approach


    § ...    less
    • August 23, 2021
  • Kevin Doe
    Kevin Doe The non-invasive
    cancer diagnostics market is estimated to be worth around USD 20.1 billion by
    ...  more
    The non-invasive
    cancer diagnostics market is estimated to be worth around USD 20.1 billion by
    2030.




    Liquid biopsies have emerged as a versatile diagnostic solution,
    especially for cases when conventional (invasive) diagnostic tests are
    inconclusive or when the clinical condition is related to an organ that is not
    amenable to biopsy access





    Roots Analysis is pleased to announce the publication of its recent study,
    titled, “Liquid Biopsy and Other Non-Invasive
    Cancer Diagnostics Market
    (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA,
    cfDNA, Exosomes and Other Biomarkers.”





    The report features
    an extensive study of the current market landscape, offering an informed
    opinion on the likely adoption of this approach over the next decade. It
    features an in-depth analysis, highlighting the capabilities of various
    stakeholders engaged in this domain. In addition to other elements, the study
    includes:


    §
    A detailed review of
    the overall landscape of the...    less
    • August 16, 2021
  • Kevin Doe
    Kevin Doe The drug
    repurposing service providers market, predicts Roots...  more
    The drug
    repurposing service providers market, predicts Roots Analysis




    Drug repurposing enables drug developers to optimize on
    past efforts and expenditure, thereby, offering a viable life cycle management
    strategy for marketed products and opportunities to re-evaluate failed /
    shelved drug development programs





    Roots Analysis is pleased to
    announce the publication of its recent study, titled, “Drug
    Repurposing Service Providers Market, 2020-2030.”





    The
    report features an extensive study of the current market landscape and future
    opportunities for players offering services for repurposing / repositioning /
    reprofiling of drug candidates. It features an in-depth analysis, highlighting
    the capabilities of various service providers engaged in this domain. In
    addition to other elements, the study includes:


    § A
    detailed assessment of the current market landscape of companies offering drug
    repurposing services.


    § Elaborate
    profiles of key players that specialize in offering...    less
    • August 16, 2021
  • Kevin Doe
    Kevin Doe Antibody drug
    conjugates market is estimated to be worth more than 15 billion in 2030,
    predicts Roots...  more
    Antibody drug
    conjugates market is estimated to be worth more than 15 billion in 2030,
    predicts Roots Analysis




    Report Keywords –
    Antibody Drug, Conjugates, Roots Analysis, Biotech, Analysis





    Antibody drug conjugates (ADCs) represent a transformative
    approach to modern cancer treatment; over the years, this upcoming class of
    targeted therapeutic agents has generated significant enthusiasm within the
    medical science community





    Roots Analysis is pleased to announce the publication of its recent
    study, titled, “ Antibody Drug Conjugates Market
    (5th Edition), 2019-2030.”





    The report features an extensive study of the current
    market landscape, offering an informed opinion on the likely adoption of these
    therapeutics over the next decade. It features an in-depth analysis, highlighting
    the capabilities of various stakeholders engaged in this domain. In addition to
    other elements, the study includes:


    §
    A
    detailed
    assessment of the current market landscape of ADCs.


    §...    less
    • August 2, 2021
View More
Loading ...

Info

Personal Information

  • First Name Kevin
  • Last Name Doe
  • Gender Male
  • Birthday January 5, 1992

Contact Information

  • Website http://www.rootsanalysis.com

Albums

  • Wall Photo­s 4 photos

Previous
Next

Blogs

  • Progressive supranuclear palsy (PSP) therapies market.

    Posted December 27, 2021

    A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers   Roots Analysis  is ...

  • Patient Recruitment and Retention Services Marker, 2019-2030 by

    Posted December 27, 2021

    A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers   Roots Analysis  is ...

  • The light activated therapies market is anticipated to grow at

    Posted December 27, 2021

    Light activated therapies are considered to be a transformative approach owing to their capability to eradicate diseased cells from the body with minimal side effects; presenting lucrative opportunities for players engaged in the development of such products   L...

  • COMPANY COMPETITIVENESS ANALYSIS - ATTAINING A COMPETITIVE EDGE

    Posted December 20, 2021

    Industry stakeholders are steadily expanding their existing capabilities in order to enhance their respective product portfolios and maintain a competitive edge in this steadily evolving market. The companies considered in this analysis have been divided into relevant p...

  • The light activated therapies market is anticipated to grow at

    Posted December 20, 2021

    Light activated therapies are considered to be a transformative approach owing to their capability to eradicate diseased cells from the body with minimal side effects; presenting lucrative opportunities for players engaged in the development of such products   L...

View All Entries
Copyright ©2025  -  Privacy  -  Terms of Service  -  Contact  -  Mobile Site

Create Account

You will use your email address to login.

 
 

Member Sign In

If you already have an account, please enter your details below. If you don't have one yet, please sign up first.

 
 
 
Forgot Password?
Share